CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

HER2 amplification / overexpression (HER2+ mCRC)

Gene: ERBB2 · Type: amplification

Indications: Colorectal cancer

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
TucatinibColorectal cancerINDICATED
FDA Label
Label
TrastuzumabColorectal cancerINDICATED
FDA Label
Label